An alternative explanation is the recent shift in emphasis on molecular diagnosis, wherein isocitrate dehydrogenase (IDH)-wildtype Grade II Astrocytomas are now instead recognized as glioblastoma. Here, IDH3A is linked to astrocytoma (excluding glioblastoma).